Scagliotti GV, et al. Nintedanib + pemetrexed/cisplatin in patients with unresectable MPM: phase III results from the LUME-Meso trial. IASLC 2018, abstract PL02.09.
“Een arts op TikTok bereikt jongeren via hun leefwereld”
apr 2024 | Longoncologie
mrt 2024
nov 2023
sep 2023